L. Kristin Newby

Safety of Selective Serotonin Reuptake Inhibitor Use Prior to Coronary Artery Bypass Grafting

C. O'connor, L. Newby, R. Krishnan, 2010, Clinical cardiology.

Fasting glucose, NT-proBNP, treatment with eptifibatide, and outcomes in non-ST-segment elevation acute coronary syndromes: An analysis from EARLY ACS.

R. Giugliano, K. Huber, R. Harrington, 2017, International journal of cardiology.

High‐Sensitivity Troponin Assays: Evidence, Indications, and Reasonable Use

Matthew W. Sherwood, L. Kristin Newby, M. Sherwood, 2014, Journal of the American Heart Association.

Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction

K. Anstrom, C. O'connor, K. Chiswell, 2021, CJC open.

Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis

Marc P. Bonaca, M. Pfeffer, R. Giugliano, 2022, European heart journal.

2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

M. Link, D. DeMets, Jeffrey L. Anderson, 2012, The Journal of thoracic and cardiovascular surgery.

Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarction.

L. Newby, W. Gibler, E. Ohman, 2007, American heart journal.

COVID-19 Infection Risk Among Previously Uninfected Adults: Development of a Prognostic Model

D. Wixted, R. Faldowski, R. Sloane, 2023, Health services research and managerial epidemiology.